Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Sep;105 Suppl 5(Suppl 5):1139-42.
doi: 10.1289/ehp.97105s51139.

Asbestos and silica-induced changes in human alveolar macrophage phenotype

Affiliations

Asbestos and silica-induced changes in human alveolar macrophage phenotype

A Holian et al. Environ Health Perspect. 1997 Sep.

Abstract

The mechanism by which fibrogenic particulates induce inflammation that can progress to lung fibrosis is uncertain. The alveolar macrophage (AM) has been implicated in the inflammatory process because of its function and reported release of inflammatory mediators when isolated from fibrotic patients. It has been recently shown that fibrogenic, but not nonfibrogenic, particulates are highly potent in inducing apoptosis of human AM. In this study, we tested the hypothesis that fibrogenic particulates could shift the phenotypic ratio of human AM to a more inflammatory condition. The macrophage phenotypes were characterized by flow cytometry targeting the RFD1 and RFD7 epitopes. Results demonstrated that chrysotile and crocidolite asbestos, as well as crystalline silica, but not titanium dioxide or wollastonite, increased the RFD1+ phenotype (inducer or immune activator macrophages) and decreased the RFD1+ RFD7+ phenotype (suppressor macrophages). These results provide a mechanistic explanation that may link apoptosis (namely, suppressor macrophages) to a shift in the ratio of macrophage phenotypes that could initiate lung inflammation.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Int J Cancer. 1968 May 15;3(3):406-8 - PubMed
    1. Am J Physiol. 1996 Nov;271(5 Pt 1):L813-9 - PubMed
    1. Scand J Immunol. 1986 Sep;24(3):351-7 - PubMed
    1. Am Rev Respir Dis. 1987 Dec;136(6):1429-34 - PubMed
    1. J Exp Med. 1988 Feb 1;167(2):262-74 - PubMed

Publication types